Kramer Levin Closes $197.5 Million Life Sciences and Technology Securitization Transaction
Kramer Levin represented the initial purchaser and the co-manager in connection with a $197.5 million securitization of life sciences and technology loans. The transaction closed on Oct. 23, 2020.
We use cookies on this website to optimize user experience and site functionality and to give you the best possible experience. We do so with your approval. The choice is up to you. Learn more.